Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AbTherx has launched the Atlas™ Mouse platform for next-generation human antibody discovery. Their technology enables the generation of fully human monoclonal and bispecific antibodies with high diversity and developability against challenging targets such as GPCRs and ion channels. The leadership team has a track record including 13 marketed therapeutics from previous platforms developed at Medarex/BMS. No direct clinical results from in-house programs have been reported; their impact comes via enabling partner pipelines[1][2][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AbTherx.